Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NASDAQ:IMUX
Recent news which mentions NASDAQ:IMUX
Immunic Inc. CEO Daniel Vitt Highlights Advances in MS Treatment on World MS Day
May 30, 2024
Tags
NASDAQ:IMUX
From
News Direct
Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day
May 20, 2024
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic chief medical officer discusses promising treatments to mark World IBD Day
May 17, 2024
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day
May 16, 2024
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones
May 09, 2024
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
IMUX Stock Earnings: Immunic Misses EPS for Q1 2024
May 08, 2024
Tickers
IMUX
Tags
Earnings Reports
NASDAQ:IMUX
Market News
From
InvestorPlace
Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
May 01, 2024
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic CEO Dr Daniel Vitt marks International Day of Immunology with discussion on its crucial role
April 29, 2024
Tags
NASDAQ:IMUX
From
News Direct
Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month
March 21, 2024
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic secures key patent, boosting MS drug exclusivity and global IP strategy
March 21, 2024
Tags
NASDAQ:IMUX
From
News Direct
Immunic to reveal promising MS treatment data in two poster presentations at ACTRIMS Forum 2024
March 08, 2024
Tags
NASDAQ:IMUX
From
News Direct
Immunic reports successful 2023 and prepares for key 2025 milestones
February 22, 2024
Tags
NASDAQ:IMUX
From
News Direct
Immunic focusing on business development during Q4
November 14, 2023
Tags
NASDAQ:IMUX
From
News Direct
Immunic CSO hails "great" progress with MS program
October 24, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic "super excited" about latest PMS trial data
October 11, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
August 21, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic CEO says Q2 results "couldn't be better"
August 07, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic Inc eyeing "big step" for multiple sclerosis patients
July 25, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic Therapeutics shares IMU-856 mode of action and target for gastrointestinal diseases
June 26, 2023
Tags
NASDAQ:IMUX
From
News Direct
Immunic ultimately hoping to "offer patients a new kind of treatment" for multiple sclerosis
May 31, 2023
Tags
NASDAQ:IMUX
From
News Direct
Immunic says preclinical data for vidofludimus calcium is a milestone for its lead MS program
May 17, 2023
Tags
NASDAQ:IMUX
From
News Direct
Immunic Inc set to bring relief with encouraging results
May 16, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic IMU-856 trial data "clearly goes beyond" initial expectations
May 04, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic gets a "positive surprise" from lead asset trial
April 13, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
2 Biotech Stocks to Take off Your Watchlist in 2022
October 19, 2022
Tags
NASDAQ:IMUX
:DNA
From
StockNews.com
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.